Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancer
European Journal of Cancer · 2023
DOI: 10.1016/j.ejca.2023.113356 ↗Kurz gefasst
Kommentar in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Daniel A Fox und 17 weiteren Autor:innen. Beteiligte Einrichtung: Margaret M. and Albert B. Alkek Department of Medicine, Baylor College of Medicine, Houston, TX, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Programmed Cell Death 1 Receptor, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: NCATS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Neoadjuvant immune checkpoint blockade (IO) is emerging as a therapeutic option for patients with deficient mismatch repair (dMMR) colorectal cancer (CRC) given high pathological response rates. The aim of the study was to characterise imaging and endoscopic response to IO. METHODS: A retrospective analysis of patients with localised dMMR CRC that received at least one cycle of neoadjuvant anti-PD-1 therapy was conducted. Endoscopy, imaging, and pathological outcomes were reviewed to determine response to treatment according to standardised criteria. RESULTS: Thirty-eight patients had received IO for the treatment of localised CRC (median eight cycles). Among evaluable cases (n = 31 for endoscopy and n = 34 for imaging), the best endoscopic response was complete response (CR) in 45% of cases, and the best radiographic response was CR in 23% of cases. Imaging CR rate after ≤4 cycles of IO (n = 1) was 6% compared to 44% after >4 IO cycles (n = 7). Among 28 patients with imaging and endoscopy available, a discrepancy in best response was noted in 15 (54%) cases. At a median follow-up of 28.2 months from IO start, 18 patients underwent surgical resection of which 11 (61%) had pathological CR (pCR). Despite pCR or no evidence of progression ≥6 months after completion of IO among non-operatively managed patients, 72% and 42% of patients had non-CR on imaging and endoscopy, respectively. CONCLUSIONS: Discrepancies between imaging and endoscopy are prevalent, and irregularities identified on these modalities can be identified despite pathological remission. Improved clinical response criteria are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Margaret M. and Albert B. Alkek Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
- Division of Cancer Medicine Fellowship Program, The University of MD Anderson Cancer Center, Houston, TX, USA.
- Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Department of Gastroenterology Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Förderung
- NCATS NIH HHS
- NCI NIH HHS
Zitieren
APA
Fox, D. A., Bhamidipati, D., Konishi, T., Kaur, H., You, N., Raghav, K. P. S., Ge, P. S., Messick, C., Johnson, B., Morris, V. K., Thomas, J. V., Shah, P., Bednarski, B. K., Kopetz, S., Chang, G. J., Ludford, K., Higbie, V. S., & Overman, M. J. (2023). Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancer. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.113356
Vancouver
Fox DA, Bhamidipati D, Konishi T, Kaur H, You N, Raghav KPS, et al. Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancer. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.113356
BibTeX
@article{Fox2023,
author = {Fox, Daniel A and Bhamidipati, Deepak and Konishi, Tsuyoshi and Kaur, Harmeet and You, Nancy and Raghav, Kanwal P S and Ge, Phillip S and Messick, Craig and Johnson, Benny and Morris, Van K and Thomas, Jane V and Shah, Preksha and Bednarski, Brian K and Kopetz, Scott and Chang, George J and Ludford, Kaysia and Higbie, Victoria Serpas and Overman, Michael J},
title = {Endoscopic and imaging outcomes of PD-1 therapy in localised dMMR colorectal cancer},
journal = {European Journal of Cancer},
year = {2023},
doi = {10.1016/j.ejca.2023.113356}
}
EUVIMED